CD30 Expression Is Frequently Decreased in Relapsed Classic Hodgkin Lymphoma after Anti-CD30 CAR T-Cell Therapy

0
257
Scientists found decreased CD30 expression in refractory/relapsed classic Hodgkin lymphoma in patients who underwent CAR T cell therapy in their institution between 2018 and 2022.
[Histopathology]
Abstract